BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16189707)

  • 1. Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk: strong confirmation of functional promoter SNP.
    Lindström S; Wiklund F; Jonsson BA; Adami HO; Bälter K; Brookes AJ; Xu J; Zheng SL; Isaacs WB; Adolfsson J; Grönberg H
    Hum Genet; 2005 Dec; 118(3-4):339-47. PubMed ID: 16189707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between CDH1 haplotypes and gastric cancer risk in a Japanese population.
    Yamada H; Shinmura K; Ikeda S; Tao H; Otani T; Hanaoka T; Tsuneyoshi T; Tsugane S; Sugimura H
    Scand J Gastroenterol; 2007 Dec; 42(12):1479-85. PubMed ID: 17852867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population.
    Imtiaz H; Afroz S; Hossain MA; Bellah SF; Rahman MM; Kadir MS; Sultana R; Mazid MA; Rahman MM
    Tumour Biol; 2019 Mar; 41(3):1010428319830837. PubMed ID: 30880589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas.
    Zhang XF; Wang YM; Ge H; Cao YY; Chen ZF; Wen DG; Guo W; Wang N; Li Y; Zhang JH
    Dis Esophagus; 2008; 21(1):21-9. PubMed ID: 18197935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA polymorphisms in exon 1 and promoter of the CDH1 gene and relevant risk of transitional cell carcinoma of the urinary bladder.
    Ma X; Xu H; Zheng T; Li HZ; Shi TP; Wang BJ; Ju ZH; Wang C; Zhang GX; Zhang X
    BJU Int; 2008 Aug; 102(5):633-6. PubMed ID: 18384629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CDH1 promoter polymorphism and the risk of non-syndromic orofacial clefts in a Chinese Han population.
    Song Y; Zhang S
    Arch Oral Biol; 2011 Jan; 56(1):68-72. PubMed ID: 20880515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. -160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer.
    Jonsson BA; Adami HO; Hägglund M; Bergh A; Göransson I; Stattin P; Wiklund F; Grönberg H
    Int J Cancer; 2004 Apr; 109(3):348-52. PubMed ID: 14961571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case-control study.
    Govatati S; Singamsetty GK; Nallabelli N; Malempati S; Rao PS; Madamchetty VK; Govatati S; Kanapuram R; Narayana N; Bhanoori M; Kassetty K; Nallanchakravarthula V
    Tumour Biol; 2014 Dec; 35(12):12059-67. PubMed ID: 25146682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of clinicopathological features with E-cadherin (CDH1) gene-160 C>A promoter polymorphism in Turkish colorectal cancer patients.
    Bahadir A; Eral G; Budak M; Shimamoto F; Korpinar MA; Erdamar S; Tuncel H
    J Cancer Res Ther; 2019; 15(1):26-31. PubMed ID: 30880750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
    Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
    Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
    Liang J; Li Y; Wang N
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhang XF; Wang YM; Wang R; Wei LZ; Li Y; Guo W; Wang N; Zhang JH
    Ai Zheng; 2005 May; 24(5):513-9. PubMed ID: 15890089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of genetic variants in and promoter hypermethylation of CDH1 with gastric cancer: a meta-analysis.
    Jing H; Dai F; Zhao C; Yang J; Li L; Kota P; Mao L; Xiang K; Zheng C; Yang J
    Medicine (Baltimore); 2014 Oct; 93(19):e107. PubMed ID: 25340495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer.
    Kiemeney LA; van Houwelingen KP; Bogaerts M; Witjes JA; Swinkels DW; den Heijer M; Franke B; Schalken JA; Verhaegh GW
    Eur J Cancer; 2006 Dec; 42(18):3219-27. PubMed ID: 16934975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation of the E-cadherin gene is associated with primary infertility in patients with ovarian endometriosis.
    Kang S; Li Y; Li B; Wang N; Zhou RM; Zhao XW
    Fertil Steril; 2014 Oct; 102(4):1149-1154.e1. PubMed ID: 25150394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive evaluation of genetic variation in the IGF1 gene and risk of prostate cancer.
    Johansson M; McKay JD; Stattin P; Canzian F; Boillot C; Wiklund F; Adami HO; Bälter K; Grönberg H; Kaaks R
    Int J Cancer; 2007 Feb; 120(3):539-42. PubMed ID: 17096324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathological development of hepatocellular carcinoma.
    Chien MH; Yeh KT; Li YC; Hsieh YH; Lin CH; Weng MS; Kuo WH; Yang SF
    J Surg Oncol; 2011 Sep; 104(3):299-304. PubMed ID: 21462191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer.
    Humar B; Graziano F; Cascinu S; Catalano V; Ruzzo AM; Magnani M; Toro T; Burchill T; Futschik ME; Merriman T; Guilford P
    Oncogene; 2002 Nov; 21(53):8192-5. PubMed ID: 12444556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CDH1-160C>A polymorphism is a risk factor for colorectal cancer.
    Pittman AM; Twiss P; Broderick P; Lubbe S; Chandler I; Penegar S; Houlston RS
    Int J Cancer; 2009 Oct; 125(7):1622-5. PubMed ID: 19569232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.